Breathwork Enters the Clinic: New Trial Shows Controlled Breathing Matches Medication for Anxiety Relief

Breathwork has taken a major step toward mainstream medical acceptance, with a new clinical trial demonstrating that daily controlled breathing exercises reduce anxiety symptoms as effectively as first-line pharmaceutical treatments.

Published in JAMA Psychiatry, the randomised controlled trial followed 572 participants with moderate to severe anxiety over 12 weeks. One group practiced 25 minutes of daily cyclic sighing — a breathwork technique involving prolonged exhalations — while the control group received standard medication. The breathwork group showed equivalent reductions in anxiety scores, with zero reports of the side effects commonly associated with anti-anxiety medications.

Researchers at Stanford University School of Medicine, who led the trial, noted that breathwork's mechanism appears to be rooted in its direct regulation of the autonomic nervous system. Controlled breathing activates the vagus nerve, triggering a cascade of physiological responses that calm the body's stress response system.

The findings arrive as the medical community increasingly seeks non-pharmacological alternatives for mental health treatment. With rising rates of anxiety worldwide and growing concerns about medication dependency, breathwork offers an accessible, cost-free intervention that requires no prescription and carries no side effects.

Lead researchers emphasised that breathwork is not a replacement for all cases but represents a powerful addition to the toolkit — particularly for patients seeking first-line options without medication.

Sources: JAMA Psychiatry, "Daily Cyclic Sighing for Anxiety: A Randomised Controlled Trial" (2026); Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences

Image: Woman meditating in nature — Unsplash

Article by Editorial Dept

#Breathwork #AnxietyRelief #MentalHealth #ClinicalStudy #Wellness